Skip to main content
Back
PANHF logo

Ping An Healthcare and Technology Company Limited

Data quality: 100%
Oversold
PANHF
OTC Healthcare Medical - Healthcare Information Services
$1.55
▼ $0.22 (-12.22%)
Mkt Cap: 3.34B
Also listed as PIAHY OTC
Day Range
$1.55 $1.55
52-Week Range
$0.78 $2.45
Volume
100
50D / 200D Avg
$1.90 / $1.62
Prev Close
$1.76

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 41.0 0.4
P/B 0.9 2.9
ROE % 1.0 3.7
Net Margin % 1.7 3.8
Rev Growth 5Y % -8.5 10.0
D/E 0.0 0.2

Key Takeaways

Revenue declined -8.52% annually over 5 years
ROE of 0.97% is below average
Debt/Equity of 0.01 — conservative balance sheet
Generating 65.09M in free cash flow
P/E of 41.02 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11.40%

Growth

Revenue Growth (5Y)
-8.52%
Revenue (1Y)2.88%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
0.97%
ROIC-1.84%
Net Margin1.69%
Op. Margin-1.85%

Safety

Debt / Equity
0.01
Current Ratio1.02
Interest Coverage-26.20

Valuation

P/E Ratio
41.02
P/B Ratio0.93
EV/EBITDAN/A
Dividend Yield1.54%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2.88% Revenue Growth (3Y) -11.97%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -8.52% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.81B Net Income (TTM) 81.43M
ROE 0.97% ROA 0.49%
Gross Margin 31.68% Operating Margin -1.85%
Net Margin 1.69% Free Cash Flow (TTM) 65.09M
ROIC -1.84% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.01 Current Ratio 1.02
Interest Coverage -26.20 Dividend Yield 1.54%
Valuation
P/E Ratio 41.02 P/B Ratio 0.93
P/S Ratio 0.69 PEG Ratio -0.66
EV/EBITDA N/A Dividend Yield 1.54%
Market Cap 3.34B Enterprise Value 1.34B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 4.81B 4.67B 6.21B 7.33B 6.87B
Net Income 81.43M -322.59M -636.06M -1.54B -948.48M
EPS (Diluted) 0.08 -0.30 -0.59 -1.39 -0.92
Gross Profit 1.52B 1.51B 1.67B 1.71B 1.86B
Operating Income -89.06M -575.26M -726.34M -1.64B -919.14M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 16.78B 16.52B 17.14B 17.88B 18.56B
Total Liabilities 13.20B 3.25B 3.68B 3.79B 2.71B
Shareholders' Equity 3.59B 13.28B 13.46B 14.08B 15.83B
Total Debt 45.00M 93.61M 176.49M 201.30M 113.97M
Cash & Equivalents 2.04B 1.87B 3.70B 3.06B 7.92B
Current Assets 13.40B 13.33B 12.46B 12.76B 15.26B
Current Liabilities 13.08B 3.10B 3.45B 3.67B 2.67B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#805 of 820
6

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026